SIGN THE NDA BY COPYING & PASTING THE LINK BELOW:

https://generational.tfaforms.net/4660083?DealID=a1LNw000000VwhF

ALL LOIs DUE BY MARCH 12, 2025

Business Highlights

Founded in 2020, the Company is manufacturer and e-commerce seller of proprietary dietary supplements for humans and pets. The Company's mix of seven products encompass a full spectrum of supplements providing comprehensive immune and metabolic health, gut, and microbiome support. The products have been sold since 2002 when they were introduced to the market by a predecessor. The Company is headquartered in New Jersey and is relocatable.

The Company’s products are manufactured using the Company’s proprietary manufacturing process. Their efficacy is validated by decades of research and pre-clinical and clinical studies. The studies confirm that the products’ active ingredient works as an immunomodulator that regulates processes of inflammation and allergy responses. It activates the mechanisms involved in antiviral protection like interferons and immunoglobulins and can help to avoid antibiotics by eliminating pathogenic bacteria. It can also serve as a probiotic and prebiotic by activating the growth of beneficial microflora, acting essentially as multiple products in one package.

INVESTMENT APPEAL

• Outstanding Growth Opportunities: There are several opportunities for the Company to significantly increase revenue and profit, including leveraging its proven reputation based on the efficacy of products to pursue and penetrate new and existing markets. These opportunities are easily attainable given the appropriate investments in capital and human resources.

• Proprietary Products: To protect its intellectual property, the Company and its shareholders have spent considerable time and investment in developing new immune and dietary supplements based on the most recent scientific approach. With proprietary strains, the Company will continue to lead the metabiotic/postbiotics/lysate market and bring new formulations for sale, enhancing customer value.

• International Reach: The Company has sold products to customers across the United States and internationally. Approximately 23% of sales came from resellers and individuals across 59 countries outside the United States.

• Strong Historical Sales Growth: Historical sales have grown from $852,000 in 2021 to $2,770,000 in the fiscal year ending December 31, 2024, representing a compound annual growth rate of 48.0%. Sales have grown consistently year over year in the historical period since 2021.

• Modest Ongoing Capital Investment Requirements: The need for capital expenditure is minimal moving forward. Capital expenditures for vehicles, and office furniture, fixtures and equipment are conservatively projected at approximately $15,000 per annum to support continued operational efficiency.

• Minimal Capital Expenditures: Over this historical period, the Company capitalized no investment in fixed assets on the balance sheet. Given the Company’s service-based operations, the future need for capital expenditures is low. The Company averaged annual capital expenditures of $1,000. Going forward, annual capital expenditures are projected to average $11,000 in the pro forma period. This improves the Company’s ability to produce free cash flows.